Recent Company News

• 08:58 AM ET Oct 05, 2026
  

  FDA seeks public comment on protocol elements relevant to ibogaine development

• 01:10 PM ET Aug 18, 2026
  

  Trump posts on Truth Social that University of Miami has given the Federal Government its original 1994 Ibogaine Investigational New Drug application

• 05:17 PM ET Jun 30, 2026
  

  XTL Biopharmaceuticals completes the acquisition of Psyga Bio ($2.73, 0.00)

• 11:18 AM ET Apr 29, 2026
  

  XTL Biopharmaceuticals to acquire Psyga Bio (0858ET) ($3.88, +1.58)

• 07:32 AM ET Mar 10, 2026
  

  Beyond Air announces termination of agreement to sell its NeuroNOS subsidiary to XTL Biopharmaceuticals ($0.86, 0.00)

• 07:32 AM ET Jan 13, 2026
  

  XTL Biopharmaceuticals Ltd. (XTLB) to acquire 85% of NeuroNOS Ltd., a subsidiary of Beyond Air ($0.88, 0.00)